Arkolith/Insider Trading/CERO/Form 4

Phoenix Biotech Sponsor, LLC

10% OwnerCERO THERAPEUTICS HOLDINGS, INC. (CERO) · full profile →Form 4 · filed Feb 16, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
6
2 non-derivative · 4 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 14, 2024Other(J)1.1M——4.2M
Feb 14, 2024Other(J)4.2M——1.0M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 14, 2024Option exercise(M)0—$00
Feb 14, 2024Option exercise(M)2K$1000.00$1.6M2K
Feb 14, 2024Other(J)350K—$00
Feb 14, 2024Other(J)2K$1000.00$1.6M0

Transaction Codes

J
Other acquisition / disposition
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001213900-24-015028) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML